"instanceType","uuid:ID","description","id","text","name","label"
"Objective","dd2d961e-91db-4d14-a320-cdf6a72f1d8d","Main objective","Objective_1","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","OBJ1",""
"Objective","06f86501-4fef-41b7-9d90-337f830b1df1","Safety","Objective_2","To document the safety profile of the xanomeline TTS.","OBJ2",""
"Objective","1ca7778d-7416-4e72-b596-ac474a733b13","Behaviour","Objective_3","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","OBJ3",""
